These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 17980013

  • 1. Vitamin D metabolites and skeletal consequences in primary hyperparathyroidism.
    Moosgaard B, Christensen SE, Vestergaard P, Heickendorff L, Christiansen P, Mosekilde L.
    Clin Endocrinol (Oxf); 2008 May; 68(5):707-15. PubMed ID: 17980013
    [Abstract] [Full Text] [Related]

  • 2. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism.
    Moosgaard B, Vestergaard P, Heickendorff L, Melsen F, Christiansen P, Mosekilde L.
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):506-13. PubMed ID: 16268801
    [Abstract] [Full Text] [Related]

  • 3. Vitamin D in Primary Hyperparathyroidism: Effects on Clinical, Biochemical, and Densitometric Presentation.
    Walker MD, Cong E, Lee JA, Kepley A, Zhang C, McMahon DJ, Silverberg SJ.
    J Clin Endocrinol Metab; 2015 Sep; 100(9):3443-51. PubMed ID: 26079779
    [Abstract] [Full Text] [Related]

  • 4. Plasma 25-hydroxyvitamin D and not 1,25-dihydroxyvitamin D is associated with parathyroid adenoma secretion in primary hyperparathyroidism: a cross-sectional study.
    Moosgaard B, Vestergaard P, Heickendorff L, Melsen F, Christiansen P, Mosekilde L.
    Eur J Endocrinol; 2006 Aug; 155(2):237-44. PubMed ID: 16868136
    [Abstract] [Full Text] [Related]

  • 5. Plasma 1,25-dihydroxyvitamin D levels in primary hyperparathyroidism depend on sex, body mass index, plasma phosphate and renal function.
    Moosgaard B, Vestergaard P, Heickendorff L, Mosekilde L.
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):35-42. PubMed ID: 17201799
    [Abstract] [Full Text] [Related]

  • 6. Low vitamin D levels have become less common in primary hyperparathyroidism.
    Walker MD, Cong E, Lee JA, Kepley A, Zhang C, McMahon DJ, Bilezikian JP, Silverberg SJ.
    Osteoporos Int; 2015 Dec; 26(12):2837-43. PubMed ID: 26084258
    [Abstract] [Full Text] [Related]

  • 7. Effect of concomitant vitamin D deficiency or insufficiency on lumbar spine volumetric bone mineral density and trabecular bone score in primary hyperparathyroidism.
    Walker MD, Saeed I, Lee JA, Zhang C, Hans D, Lang T, Silverberg SJ.
    Osteoporos Int; 2016 Oct; 27(10):3063-71. PubMed ID: 27198233
    [Abstract] [Full Text] [Related]

  • 8. Vitamin D supplementation after parathyroidectomy: effect on bone mineral density-a randomized double-blind study.
    Norenstedt S, Pernow Y, Zedenius J, Nordenström J, Sääf M, Granath F, Nilsson IL.
    J Bone Miner Res; 2014 Apr; 29(4):960-7. PubMed ID: 24115138
    [Abstract] [Full Text] [Related]

  • 9. Skeletal effects of vitamin D deficiency among patients with primary hyperparathyroidism.
    Lee JH, Kim JH, Hong AR, Kim SW, Shin CS.
    Osteoporos Int; 2017 May; 28(5):1667-1674. PubMed ID: 28175978
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism.
    Christensen SE, Nissen PH, Vestergaard P, Heickendorff L, Rejnmark L, Brixen K, Mosekilde L.
    Eur J Endocrinol; 2008 Dec; 159(6):719-27. PubMed ID: 18787045
    [Abstract] [Full Text] [Related]

  • 14. BMD improvements after operation for primary hyperparathyroidism.
    Rolighed L, Vestergaard P, Heickendorff L, Sikjaer T, Rejnmark L, Mosekilde L, Christiansen P.
    Langenbecks Arch Surg; 2013 Jan; 398(1):113-20. PubMed ID: 23132462
    [Abstract] [Full Text] [Related]

  • 15. 1,25-dihydroxyvitamin D and the vitamin D receptor gene polymorphism Apa1 influence bone mineral density in primary hyperparathyroidism.
    Christensen MH, Apalset EM, Nordbø Y, Varhaug JE, Mellgren G, Lien EA.
    PLoS One; 2013 Jan; 8(2):e56019. PubMed ID: 23418495
    [Abstract] [Full Text] [Related]

  • 16. The effect of high-dose vitamin D supplementation on calciotropic hormones and bone mineral density in obese subjects with low levels of circulating 25-hydroxyvitamin d: results from a randomized controlled study.
    Wamberg L, Pedersen SB, Richelsen B, Rejnmark L.
    Calcif Tissue Int; 2013 Jul; 93(1):69-77. PubMed ID: 23591713
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Associations of 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D With Bone Mineral Density, Bone Mineral Density Change, and Incident Nonvertebral Fracture.
    Swanson CM, Srikanth P, Lee CG, Cummings SR, Jans I, Cauley JA, Bouillon R, Vanderschueren D, Orwoll ES, Nielson CM, Osteoporotic Fractures in Men MrOS Study Research Group.
    J Bone Miner Res; 2015 Aug; 30(8):1403-13. PubMed ID: 25707402
    [Abstract] [Full Text] [Related]

  • 20. Clinical, Biochemical, and Radiological Profile of Normocalcemic Primary Hyperparathyroidism.
    Palermo A, Naciu AM, Tabacco G, Falcone S, Santonati A, Maggi D, D'Onofrio L, Briganti SI, Castellitto D, Casini A, Pedone C, Lelli D, Fabbri A, Bilezikian JP, Napoli N, Pozzilli P, Manfrini S, Cesareo R.
    J Clin Endocrinol Metab; 2020 Jul 01; 105(7):. PubMed ID: 32271382
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.